03-Nov-2026 17:56:11
ANTHEM BIOSCIENCES Q2 FY27 ; NET PROFIT UP 22% AT ₹211 CR (YOY), UP 76% (QOQ)
REVENUE UP 8% AT ₹594 CR (YOY), UP 42% (QOQ) EBITDA UP 24% AT ₹271 CR (YOY), UP 80% (QOQ) MARGINS AT 45.7% VS 39.7% (YOY), 36.0% (QOQ)
Latest market headlines for ANTHEM on Terminal.
03-Nov-2026 17:56:11
REVENUE UP 8% AT ₹594 CR (YOY), UP 42% (QOQ) EBITDA UP 24% AT ₹271 CR (YOY), UP 80% (QOQ) MARGINS AT 45.7% VS 39.7% (YOY), 36.0% (QOQ)
03-Nov-2026 17:55:16
Revenue up 7.9% at ₹594.03 Cr (YOY), up 42.0% (QOQ). Ebitda up 24.1% at ₹330.39 Cr (YOY), up 88.3% (QOQ); margins 55.6% v 48.4% (YOY), 42.0% (QOQ).
08-Jul-2026 12:42:37
• Promoter Ishaan Bhardwaj declares no encumbrance over shares held directly or indirectly during the financial year ended March 31, 2026. • Disclosure is made…